Clynes M - Search Results

1

Identification of microRNAs with a role in glucose stimulated insulin secretion by expression profiling of MIN6 cells.

Hennessy E, Clynes M, Jeppesen PB, O'Driscoll L. Hennessy E, et al. Among authors: clynes m. Biochem Biophys Res Commun. 2010 May 28;396(2):457-62. doi: 10.1016/j.bbrc.2010.04.116. Epub 2010 Apr 24. Biochem Biophys Res Commun. 2010. PMID: 20417623

2

The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells.

O'Driscoll L, Daly C, Saleh M, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Cytotechnology. 1993;12(1-3):289-314. doi: 10.1007/BF00744669. Cytotechnology. 1993. PMID: 7509167 Review.

3

Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue.

O'Driscoll L, Kennedy S, McDermott E, Kelehan P, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Eur J Cancer. 1996 Jan;32A(1):128-33. doi: 10.1016/0959-8049(95)00552-8. Eur J Cancer. 1996. PMID: 8695220

4

mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.

Daly C, Coyle S, McBride S, O'Driscoll L, Daly N, Scanlon K, Clynes M. Daly C, et al. Among authors: clynes m. Cytotechnology. 1996;19(3):199-205. doi: 10.1007/BF00744213. Cytotechnology. 1996. PMID: 8862007

5

Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.

Heenan M, O'Driscoll L, Cleary I, Connolly L, Clynes M. Heenan M, et al. Among authors: clynes m. Int J Cancer. 1997 May 29;71(5):907-15. doi: 10.1002/(sici)1097-0215(19970529)71:5<907::aid-ijc33>3.0.co;2-1. Int J Cancer. 1997. PMID: 9180164

6

Engineering Vero cells to secrete human insulin.

O'Driscoll L, Gammell P, Clynes M. O'Driscoll L, et al. Among authors: clynes m. In Vitro Cell Dev Biol Anim. 2002 Mar;38(3):146-53. doi: 10.1290/1071-2690(2002)038<0146:EVCTSH>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2002. PMID: 12026163

7

Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.

O'Driscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Anticancer Res. 2002 Nov-Dec;22(6A):3117-25. Anticancer Res. 2002. PMID: 12530054

8

Prognostic importance of survivin in breast cancer.

Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M, Linehan R, Clynes M. Kennedy SM, et al. Among authors: clynes m. Br J Cancer. 2003 Apr 7;88(7):1077-83. doi: 10.1038/sj.bjc.6600776. Br J Cancer. 2003. PMID: 12671708 Free PMC article.

9

Survivin: role in normal cells and in pathological conditions.

O'Driscoll L, Linehan R, Clynes M. O'Driscoll L, et al. Among authors: clynes m. Curr Cancer Drug Targets. 2003 Apr;3(2):131-52. doi: 10.2174/1568009033482038. Curr Cancer Drug Targets. 2003. PMID: 12678716 Review.

10

Challenges in molecular analysis for individualized cancer therapy.

Clynes M, O'Connor R, O'Driscoll L, Daly C, Meleady P. Clynes M, et al. Drug Discov Today. 2003 Jun 15;8(12):531. doi: 10.1016/s1359-6446(03)02730-2. Drug Discov Today. 2003. PMID: 12821298 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters